GadoBoost AI virtually enhances contrast uptake in T1-weighted 3D brain MRI scans and automatically detects contrast-enhancing lesions. It is particularly designed for scenarios where subtle findings need to be identified, such as follow-up examinations of patients with cancers that commonly metastasize to the brain. By increasing the conspicuity of subtle enhancing findings and supporting radiologists with automated detection, GadoBoost AI aims to improve confidence during routine assessment of potentially negative examinations.